Competition Tests Novo Nordisk’s Grip on Weight-Loss Drug MarketBusiness PenFebruary 4, 2026April 22, 2026 February 4, 2026April 22, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”NVO” realtime=”true” api=”yahoo-finance”] Novo Nordisk A/S (NYSE: NVO) surprised investors this week by warning that its sales may decline this year, marking...